US2022387596A1PendingUtilityA1

Biodegradable hydrogel and methods for use thereof

Assignee: IBMPriority: Nov 21, 2018Filed: Aug 1, 2022Published: Dec 8, 2022
Est. expiryNov 21, 2038(~12.3 yrs left)· nominal 20-yr term from priority
C08G 65/3317C08G 65/3348C08L 2203/02A61K 9/06C08G 64/0241C08G 64/183B01J 13/04B01J 13/0052C08G 65/337C08L 69/00C08G 65/3326A61K 9/107B01J 13/10C08G 81/00C08G 64/42C08J 3/075A61K 31/69C08G 64/305C08G 64/0275C08L 71/02A61K 47/34C08G 65/333C08G 64/025A61K 9/1075C08L 2205/025
80
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The subject matter of this invention relates to hydrogel compositions and, more particularly, to hydrogel compositions comprising block copolymers (BCPs) capable of self-assembly into nanoparticles for the delivery and controlled release of therapeutic cargos.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A hydrogel composition comprising:
 an AB diblock copolymer having a negatively charged A block; and   an ABA triblock copolymer having positively charged A blocks.   
     
     
         2 . The hydrogel composition of  claim 1 , wherein the AB diblock copolymer is a catechol-functionalized polycarbonate/poly(ethylene glycol) (PEG) AB diblock copolymer. 
     
     
         3 . The hydrogel composition of  claim 2 , wherein the AB diblock copolymer has the structure of formula IV: 
       
         
           
           
               
               
           
         
         wherein m is between 1 and 10 and MPEG 10K  is 10 kDa methyl-poly(ethylene glycol). 
       
     
     
         4 . The hydrogel composition of  claim 3 , wherein m is 5. 
     
     
         5 . The hydrogel composition of  claim 1 , wherein the ABA triblock copolymer includes A blocks containing either guanidine or thiouronium. 
     
     
         6 . The hydrogel composition of  claim 5 , wherein the ABA triblock copolymer has the structure of formula II: 
       
         
           
           
               
               
           
         
         wherein x is between 1 and 10, n is 227, and TFA is trifluoroacetic acid. 
       
     
     
         7 . The hydrogel composition of  claim 6 , wherein x is 5. 
     
     
         8 . The hydrogel composition of  claim 5 , wherein the ABA triblock copolymer has the structure of formula III: 
       
         
           
           
               
               
           
         
         wherein m is between 1 and 10 and n is 227. 
       
     
     
         9 . The hydrogel composition of  claim 8 , wherein m is 5. 
     
     
         10 . A micellar particle comprising:
 a hydrogel composition comprising:
 an AB diblock copolymer having a negatively charged A block; and 
 an ABA triblock copolymer having positively charged A blocks; and 
   at least one agent for delivery within the hydrogel composition.   
     
     
         11 . The micellar particle of  claim 10 , wherein:
 the AB diblock copolymer is a catechol-functionalized polycarbonate/poly(ethylene glycol) (PEG) AB diblock copolymer having the structure of formula IV:   
       
         
           
           
               
               
           
         
         wherein m is between 1 and 10 and MPEG 10K  is 10 kDa methyl-poly(ethylene glycol); and 
         the ABA triblock copolymer has the structure of formula II or formula III: 
       
       
         
           
           
               
               
           
         
         wherein x is between 1 and 10, n is 227, and TFA is trifluoroacetic acid 
       
       
         
           
           
               
               
           
         
         wherein m is between 1 and 10 and n is 227.

Join the waitlist — get patent alerts

Track US2022387596A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.